Memorial Sloan Kettering Cancer Center

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Myeloma
Leukemia
Lymphoma
Hematologic Transplantation and Malignancies
Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic
Skin
Head and Neck
Brain
General Oncology
Palliative Care
MPN
COVID-19
Events

Playback speed

10 seconds

PI3Ki's in Indolent Lymphoma: Overview of Approved Drugs, Trial Based Data on Toxicity and Efficacy of Upcoming PI3Ki's, and the Pre-Clinical Rationale of PI3Ki's+Targeted

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Andrew Zelenetz

68 views

October 18, 2019

Comments 0

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Lymphoma

Key Lymphoma Updates From ASH

Memorial Sloan Kettering Cancer Center

P. Torka

374 views

SOHO 2023: What Is High Risk MCL and How Should We Treat It

SOHO 2023 Eleventh Annual Meeting

A. Kumar

194 views

The Evolving 1L DLBCL Landscape: POLARIX, Novel Agents and Future Di…

MedNews Week

M. Matasar

290 views

Current Management of Newly Diagnosed DLBCL

MedNews Week

M. Matasar

43 views

2023 SOHO® Brazil: "Moving Beyond CHOP/CHOEP - How Disease Features …

SOHO Brazil 2023

A. Moskowitz

86 views

Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellul…

Indy Hematology Review

G. Salles

154 views

ASCO 2022 on the Initial Safety Run-in Results of the Phase III POLA…

ASCO 2022 Conference Coverage

M. Matasar

76 views

ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Stud…

ASCO 2022 Conference Coverage

C. Lee Batlevi

64 views

Lecture Summary - ASCO 2022 Updated Interim Analysis of the Randomiz…

ASCO 2022 Conference Coverage

C. Lee Batlevi

19 views

SOHO 2021: The Next Wave of Novel Agents in Aggressive B-Cell Lympho…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

G. Salles

22 views

MSKCC 2021 Update on Therapeutic Advances in T-Cell Lymphoma: Subtyp…

i3 Health

S. Horwitz

142 views

24:05

SOHO Highlights: State of the Art and Next Questions

SOHO Highlights on Non-Bulky cHL: Can We Treat Early Disease With Sh…

Feat. D. Straus

Early Stage cHL Management: Bulky vs. Non-bulky Disease, Better Chem…

SOHO Highlights: State of the Art and Next Questions

D. Straus

174 views

2020 SOHO Update on R/R PTCL: Is There a Single Paradigm Overall? Ca…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

S. Horwitz

112 views

2020 SOHO Highlights on Newly Diagnosed HL: Is ABVD Chemo Regimen Be…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

D. Straus

127 views

2020 SOHO Updates on R/R cHL: Can We Improve Chemo With ADCs and CPI…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

D. Straus

56 views

2020 SOHO Update on DLBCL: CAR-T vs. autoHCT for Early Relapsed Dise…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

S. Giralt

28 views